Generic substitution of itraconazole resulting in subtherapeutic levels and resistance

被引:38
作者
Pasqualotto, Alessandro Comaru [1 ]
Denning, David W. [1 ]
机构
[1] Univ Manchester, Wythenshawe Hosp, Sch Med, Manchester, Lancs, England
关键词
D O I
10.1016/j.ijantimicag.2006.11.027
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:93 / 94
页数:2
相关论文
共 5 条
[1]   Chronic cavitary and Fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review [J].
Denning, DW ;
Riniotis, K ;
Dobrashian, R ;
Sambatakou, H .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S265-S280
[2]  
*EMEA, GUID INV BIO BIO
[3]   BIOASSAY FOR SERUM ITRACONAZOLE CONCENTRATIONS USING HYDROXYITRACONAZOLE STANDARDS [J].
LAW, D ;
MOORE, CB ;
DENNING, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1561-1566
[4]  
Prentice AG, 2005, J ANTIMICROB CHEMOTH, V56, P17
[5]   Practice guidelines for diseases caused by Aspergillus [J].
Stevens, DA ;
Kan, VL ;
Judson, MA ;
Morrison, VA ;
Dummer, S ;
Denning, DW ;
Bennett, JE ;
Walsh, TJ ;
Patterson, TF ;
Pankey, GA .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :696-709